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Abstract
Background: To investigate neurobiological correlates of trait anxiety, CD1 mice were selectively bred for extremes in
anxiety-related behavior, with high (HAB) and low (LAB) anxiety-related behavior mice additionally differing in behavioral
tests reflecting depression-like behavior.
Methodology/ Principal Findings: In this study, microarray analysis, in situ hybridization, quantitative real-time PCR and
immunohistochemistry revealed decreased expression of the vasopressin gene (Avp) in the hypothalamic paraventricular
(PVN) and supraoptic (SON) nuclei of adult LAB mice compared to HAB, NAB (normal anxiety-related behavior) and HABxLAB
F1 intercross controls, without detecting differences in receptor expression or density. By sequencing the regions 2.5 kbp
up- and downstream of the Avp gene locus, we could identify several polymorphic loci, differing between the HAB and LAB
lines. In the gene promoter, a deletion of twelve bp D(22180–2191) is particularly likely to contribute to the reduced Avp
expression detected in LAB animals under basal conditions. Indeed, allele-specific transcription analysis of F1 animals
revealed a hypomorphic LAB-specific Avp allele with a reduced transcription rate by 75% compared to the HAB-specific
allele, thus explaining line-specific Avp expression profiles and phenotypic features. Accordingly, intra-PVN Avp mRNA levels
were found to correlate with anxiety-related and depression-like behaviors. In addition to this correlative evidence, a
significant, though moderate, genotype/phenotype association was demonstrated in 258 male mice of a freely-segregating
F2 panel, suggesting a causal contribution of the Avp promoter deletion to anxiety-related behavior.
Discussion: Thus, the identification of polymorphisms in the Avp gene promoter explains gene expression differences in
association with the observed phenotype, thus further strengthening the concept of the critical involvement of centrally
released AVP in trait anxiety.
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Introduction
Despite decades of intensive research, anxiety and depression
disorders remain two of the most common and debilitating
psychiatric illnesses. Their causes and appropriate medication are
still elusive [1], and the number of affected people continues to
increase [2,3]. Depression is a highly heritable disorder;
epidemiologic studies have shown that about 40–50% of the risk
for depression is genetically determined [4,5] and that depression
is in 60% of all cases comorbid with anxiety disorders [6,7]. These
findings are strongly supported by familial and twin studies [8].
However, the considerable evidence for heritability has not been
accompanied by satisfactory progress towards identifying genetic
risk factors underlying anxiety and depression. An improved
understanding of the genetic contributions would have significant
implications for the diagnosis and treatment of neuropsychiatric
disorders.
In order to identify shared genotype/phenotype relationships in
animals and humans, the same gene should affect analogous
phenotypes in both species. Thus, a useful approach should
depend on conserved gene function, the presence of functional
polymorphisms in this gene in both species and the choice of an
appropriate analogous phenotype in both the model species and in
humans [9]. The gene for the nonapeptide vasopressin (AVP)
fulfills all these requirements. It is evolutionary conserved as both
antidiuretic hormone after peripheral secretion and anxiogenic
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over, the presence of functional polymorphisms and subsequent
deficits in expression/processing in rodents and patients leads to
signs of both central diabetes insipidus and emotional alterations,
e.g. decreased anxiety-related behavior [13–16]. Finally, trait
anxiety with the genetic predisposition towards either high (HAB)
or low (LAB) anxiety-related behavior is a heuristically and
clinically relevant phenotype, with a high degree of face, construct
and predictive validity [17].
Preclinical studies, including findings from the HAB/LAB rat
model [18–21] and voles [22], as well as clinical observations [23]
support a direct involvement of centrally released AVP in
anxiety/depression-like behaviors and disorders. To make use of
the advantages of the full spectrum of molecular-genetic
approaches, CD1 mice were selectively inbred for either low or
high anxiety-related behavior in analogy to the HAB/LAB rat
model, while maintaining a high degree of similarity in non-
selected traits. Along with their divergence in anxiety-related
behavior, which is reflected in a variety of distinct behavioral
paradigms, these mouse lines also exhibit differences in tests of
other metrics, including depression-like and explorative behaviors
[24]. The final goal of our selective breeding strategy is to identify
candidate genes of anxiety and to prove their causal involvement
in the anxiety phenotype, while simultaneously reducing the
possible influence of genetic drift and the concomitant risk of
indicating false associations between the gene of interest and a
given phenotype, a risk particularly high in inbred lines or strains.
Therefore, a series of measures have been employed in order to
minimize the risk related to genetic drift: (i) in each selectively
bred line, several independent sublines are run in parallel; (ii)
identified genetic polymorphisms are tested in a freely-segregat-
ing F2 panel and are accepted to be causal if they co-segregate
with the phenotype; (iii) in addition to the divergent lines, normal
anxiety (NAB) mice are used to represent intermediate anxiety-
related behavior; and (iv) replication is important in terms of the
impact of founder effects and genetic drift and should be run
concurrently with the main breeding protocol in the same or
another species, thus also facilitating complementary inter-species
genetics [9].
Therefore, if Avp gene expression is causally related to the HAB
vs. LAB phenotype, genetic polymorphisms contributing to this
phenomenon should be detectable not only in selectively bred rats
but also in mice. Indeed, LAB mice display a deficit in
hypothalamic AVP [25]. In light of the functional impact of
polymorphisms in the Avp regulatory regions for both gene
expression and anxiety-related behavior in rats [18], we here
addressed the question whether polymorphisms in the Avp
promoter of LAB mice may be identified and contribute to the
neuroendocrine and behavioral divergence demonstrated in HAB
vs. LAB mice. This will provide new insights into the genetic
predisposition that shapes emotionality in both inter-individual
variation and psychopathology.
Materials and Methods
Animals
All animals tested were bred in the animal facilities of the Max
Planck Institute of Psychiatry in Munich (Germany) as described
previously [24]. Briefly, .250 animals from .25 litters of outbred
Swiss CD1 mice purchased from Charles River (Sulzfeld,
Germany) were used as a starting point for selective and
bidirectional breeding for anxiety-related behavior on the elevated
plus-maze (EPM) at the age of seven weeks. Males and females
that spent either the least or most time on the open arms of the
EPM were mated to establish the HAB and LAB lines,
respectively. This intra-strain approach was chosen to ensure that
the HAB/LAB lines show a maximum divergence in the selected
trait, while maintaining a high degree of similarity in non-selected
traits. The animals were routinely tested at the age of seven weeks,
with HAB mice spending ,10% and LAB .50% of the total test
time on the open arms of the EPM. NAB mice were bred for
intermediate anxiety-related behavior. As .80% of CD1 mice
spend between 25% and 35% of their time on the open arms of
the EPM, this range was chosen for the selection of NAB mice
without any overlapping either with LAB or with HAB animals.
While CD1 mice of the parental generation were used as NAB
controls by Kro ¨mer et al. [24] and Kessler et al. [25], we then
decided to start inbreeding them in parallel with HAB and LAB
mice, aiming at further reducing all variables that are unrelated to
anxiety, such as slight differences in body weight between outbred
vs. inbred animals.
All experiments were carried out on adult male or female
HAB, LAB, NAB, HABxLAB F1 intercross and F2 mice. In the
present study, HAB and LAB mice of generations 12–23 and
NAB mice of generation 1 were used. Importantly, in a wide
variety of tests and parameters, the scores of NAB and F1
intercross controls were found to be similar, if not identical, and
between the scores of HAB and LAB mice ([24]; unpublished
results).
The animal studies were both approved by local authorities and
conducted according to current regulations for animal experi-
mentation in Germany and the European Union (European
Communities Council Directive 86/609/EEC).
EPM test
The EPM consisted of a plus-shaped platform elevated 37 cm
above the floor, with two open (3065 cm), two closed
(3065615 cm) arms and a connecting central zone (565 cm)
made of grey PVC. The open arms were lit by white light of
300 lux intensity, the neutral zone of 60 lux intensity and the
closed arms of 5 lux intensity. The maze was cleaned with water
containing a detergent and dried before each trial.
Animals were directly transferred from their homecage to the
test apparatus, starting with the animal placed on the central
part facing one closed arm. During the 5-min exposure, various
parameters were recorded by means of a video/computer
system. Analysis was performed post hoc by an observer blind to
the line using Plus-maze V2.0 (Ernst Fricke, Munich, Germany)
[24,26].
Tail-suspension test
In the tail-suspension test, animals were suspended at the end of
their tail to a bar at a height of 37 cm above the floor with an
adhesive tape [27]. Four animals were tested in parallel during
each test. The behavior was videotaped and the duration of total
immobility (immobility of all four extremities) scored by an
observer blind to the line using Eventlog 1.0 (EMCO Software,
Reykjavik, Iceland).
Forced swim test
In the forced swim test each mouse was placed for 6 min into a
glass cylinder (height: 23 cm; diameter: 11 cm) containing 15 cm
of water at 22–23uC. For each videotaped trial, immobility time
(floating) was analyzed by an observer blind to the line using
Eventlog 1.0 (EMCO Software). A mouse was judged immobile
when it stopped any slight movements, except those that are
necessary to keep its head above water [28].
Effects of AVP on Emotionality
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The round open field, having a diameter of 60 cm, was made of
black and grey PVC and was optically divided into an inner
(diameter: 30 cm) and an outer area to allow quantification of the
time spent in each compartment. To devise the test situation as less
aversive as possible and to make the test suitable to measure
locomotor activity independent of anxiety, the arena was
illuminated with dim light of 60 lux. Before each trial, the
chamber was cleaned with water containing a detergent. The
animals’ behavior was videotaped during the 5-min test time and
the parameter path length was analyzed with the tracking software
ANY-maze version 4.30 (Stoelting, Wood Dale, IL, USA).
Gene and peptide expression profiling
If not indicated otherwise, all animals used for gene and peptide
expression profiling or receptor radioautography were sacrificed
by decapitation under isoflurane anesthesia (Abbott, Wiesbaden,
Germany), between 9a.m. and 12p.m. The brains were removed,
snap-frozen in N-methylbutane (Carl Roth, Karlsruhe, Germany)
and stored at 220uCo r280uC.
Tissue sampling for microarray and quantitative real-
time PCR. The tissue micropunching technique [29] was
applied for acquiring tissue samples from specific regions with
micropunchers of 0.5 mm and 1 mm diameter (Fine Science
Tools GmbH, Heidelberg, Germany). Punches were collected
from 200 mm sections between 20.56 mm and 20.96 mm from
bregma, medially 0.8 mm above the ventral tissue edge around the
dorsal end of the 3
rd ventricle to obtain the PVN (Ø=1 mm) and
bilaterally from the optic tract (Ø=0.5 mm) in order to acquire
tissue from the SON. All coordinates were based on the mouse
brain atlas [30]. Tissue punches were kept at 280uC until further
processing.
RNA extraction and reverse transcription from tissue
punches. Tissue punches were homogenized with a pipette in
300 ml Trizol (Tri Reagent, Sigma-Aldrich). Then 30 ml bidistilled
water, 1 ml linear acrylamide (5 mg/ml, Ambion, Austin, TX) and
60 ml chloroform were added before continuing RNA extraction
with a standard protocol, using n-propanol for RNA precipitation
overnight. The yield of total RNA was 0.3–1.5 mg.
All isolated RNA was further processed for microarray analysis
using the Ambion Amino Allyl Message Amp aRNA kit (Ambion)
in two rounds of amplification. For qPCR, not more than 1 mgo f
total RNA was reverse transcribed with Superscript II (Invitrogen,
Karlsruhe, Germany) after DNAse treatment. All steps required
for reverse transcription were performed according to the
manufacturer’s protocol. For quality control, a small aliquot of
cDNA was analyzed on an agarose gel.
Microarray analysis. Whole-genome gene expression data
were acquired using a dual-color experimental design (cyanine 3
and cyanine 5) on an in-house microarray platform (MPI24K)
with pooled samples (six LAB vs. six HAB male mouse brain pools)
using ten technical replicates including a dye-swap of the
hybridized samples on five microarray slides. Pretreatment of
microarray probes, assay hybridization, scanning, data evaluation
and statistical analysis were performed as described previously
[31,32]. Briefly, microarray slides were scanned in a PerkinElmer
ScanArray 4000 (PerkinElmer Life and Analytical Sciences,
Shelton, CT) and quantified using QuantArray software (GSI
Lumonics, Billerica, MA) with a fixed-circle quantification
protocol. Data normalization was performed in multiple steps
based on the raw fluorescence intensities ensuring the elimination
of artifacts resulting from the unequal distribution of probes or
from unbalanced fluorescence intensities within one microarray
slide.
Quantitative PCR analysis. cDNA of male or female, LAB,
HAB or NAB mice was analyzed by quantitative real-time PCR
(qPCR), using the LightCyclerH FastStart DNA MasterPLUS
SYBR Green I reagent (Roche Diagnostics, Mannheim, Germany)
or the QuantiFast SYBR Green PCR Kit (Qiagen, Hilden,
Germany) according to the manufacturer’s instructions and the
respective oligonucleotide primers for Avp, Avpr1b, Oxtr. For
reaction conditions and primer sequences see Table 1.
Experiments were performed in duplicates with the
LightcyclerH2.0 instrument (Roche Diagnostics) under the
following PCR conditions: initial denaturation at 95uC for
10 min, then 40 cycles of denaturation (95uC for 10 s),
annealing (56–65uC for 4–5 s) and elongation (72uC, 7–13 s) for
the Roche-kit. Similar conditions were applied for the Qiagen-kit,
only the annealing and extension phase were standardly
substituted by a combined annealing/extension phase at 60uC
for 30 s. At the end of every run, a melting curve (50–95uC with
0.1uC/s) was generated in order to ensure the homogenity of the
PCR product.
Crossing points were calculated by the LightCyclerHSoftware
4.0 (Roche Diagnostics) using the absolute quantification fit points
method. Threshold and noise band were set to the same level in all
compared runs.
Relative gene expression was determined by the 2
2DDCT
method [33] using the real PCR efficiency calculated from an
external standard curve. The crossing point was normalized to the
housekeeping genes Gapdh, Hprt and Atp2b1 (Table 1), respectively
and values were calculated relative to the expression mean of LAB
mice.
Avp and Oxytocin mRNA in situ hybridization. Brains
were sectioned into 14 mm slices with a cryostat (Microm HM 500,
Microm, Walldorf, Germany). Three sets of sections at PVN level
were taken and used for Avp or Oxytocin (Oxt) in situ hybridization
(ISH) according to established protocols [20,34].
Briefly, sections were dehydrated in increasing ethanol concen-
trations, delipidated with chloroform, rinsed in ethanol and air-
dried afterwards. A highly specific 48-bp oligonucleotide sequence
directed against the last 16 amino acid coding region of the
glycoprotein that AVP does not share with OXT (59 GGG CTT
GGC AGA ATC CAC GGA CTC TTG TGT CCC AGC CAG
CTG TAC CAG 39; [35,36]) was used for hybridization with Avp.
Detection of Oxt mRNA was performed by hybridization of a
similarly specific 48-bp oligonucleotide (59 CTC GGA GAA GGC
AGA CTC AGG GTC GCA GGC GGG GTC GGT GCG GCA
GCC 39; [35]). The oligonucleotides were labeled by using
[
35S]ATP (NEN DuPont, Bad Homburg, Germany) and terminal
transferase (Tdt, Boehringer, Mannheim, Germany) and purified
by tRNA (Sigma, Germany) precipitation. Tissue sections (5
sections per slide) were saturated with 100 ml of hybridization
buffer (deionized formamide, 206SSC, dextran sulfate, 0.2 M Na-
phosphate buffer, Dehnhard’s solution, 20% sarcosyl, salmon
sperm DNA, 5 M DTT (DL-Dithiothreitol)) containing 10
6 cpm/
100 ml for the Avp-
35S and 0.5610
6 cpm/100 ml for the Oxt-
35S
oligoprobe. Coverslipped sections were incubated in a moist
chamber for 18–22 h at 45uC. After several washes in 16SSC, the
sections were dehydrated and air-dried [20]. For all following steps
see section of data analysis below.
AVP immunohistochemistry in the PVN. Immunohisto-
chemistry was performed as described previously [37]. In brief,
animals were deeply anaethesized by an overdose of sodium
pentobarbital (200 mg/kg) by i.p. injection prior to cardiac
perfusion. Brains of these unstressed mice were removed and
postfixed at 4uC in 4% paraformaldehyd over night and then
stored in 0.2 M phosphate buffer until sectioning.
Effects of AVP on Emotionality
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Vibratome (Series 1000, Ted Pella Inc., Redding, CA) sections
(50 mm) were preincubated in immunobuffer containing 5%
normal donkey serum (Jackson ImmunoResearch, West Grove,
PA) and then incubated for 48 h at room temperature with a
polyclonal rabbit antibody to AVP (dilution 1:10000, Peninsula
Laboratories, Belmont, CA). Sections were exposed for 2.5 h to a
Cy2-conjugated donkey anti-rabbit IgG (dilution 1:100, Jackson
ImmunoResearch). Negative controls were performed by
omission of the primary antibodies. No staining was observed
in any of the control sections. Images were recorded on a
fluorescence microscope (Olympus BX-51, Vienna, Austria),
equipped with a U-M41001 filter system (excitation filter, 455–
495 nm; dichromatic mirror, 505 nm; emission filter, 510–
555 nm) for Cy2 (excitation maximum 492 nm; emission
maximum 510 nm), using a digital camera (Olympus DP50)
and analySISH image processing software (Soft Imaging Systems,
Mu ¨nster, Germany).
AVP receptor 1a autoradiography. For AVP receptor 1a
(V1a) autoradiography, frozen cryostat brain sections (14 mm) of
HAB and LAB mice were utilized and processed as described
elsewhere [20]. Before incubation, the slides were fixed using 0.1%
PFA and washed in Tris buffer. For competitive displacement of
endogenous AVP and for receptor binding, slides were incubated
(60 min, RT) with the AVP V1a-R antagonist
125I-lin AVP
(NEX310, NEN DuPont, Boston, MA; 200 cpm/ml). After several
washes, the slides were air-dried.
Data analyses. For all ISHs and receptor binding analyses,
the sections were exposed to a Kodak BioMax film (Amersham,
Braunschweig, Germany) for 1–3 days (increased exposure time
for Oxt due to the lower amount of labelled oligoprobe).
Autoradiographs were quantified using an image analysis optical
software (Optimas 5.2, Optimas Corporation, Seattle, WA).
Autoradiograms from ISH and receptor binding studies were
analyzed using the optical density readings (grey intensity). Three
to six sections were analyzed and the highest expression (measured
as hybridization signal minus background) per animal was taken
for calculating mean hybridization per nucleus and line [20]. Due
to the high expression of Avp and Oxt mRNAs in the hypothalamic
PVN and SON, we focused on these nuclei in LAB, HAB, NAB or
F1 animals. For V1a receptor autoradiography, the amygdala, bed
nucleus of the stria terminalis, hippocampus, lateral septum, PVN,
SON, suprachiasmatic nucleus and ventral pallidum were
analyzed.
Avp sequencing
GenomicDNAwaspurifiedfromtailtissueclipsofHABandLAB
mice from the 20
th generation, using the NucleoSpin Tissue kit
(Macherey-Nagel, Du ¨ren, Germany). The Avp coding sequence [25]
as well as 3 kbp up- and downstream the coding region were
amplified using 12 primer pairs (MWG Biotech, Ebersberg,
Germany; Table 2). All PCR amplifications were carried out by
using Taq polymerase (Fermentas, St. Leon-Rot, Germany) in 25-ml
reactionsunderthefollowingconditions:initialdenaturationat 94uC
for4 min,40cycles of denaturation (94uC for1 min),annealing(52–
56uC for 1 min) and extension (72uCfor1 min),concluded bya final
extension of 10 min at 72uC. Purification of the PCR products was
performed with the NucleoFast kit (Macherey-Nagel). Then, the PCR
products were ligated into the pGEM-T vector (Promega Corp.,
Madison, WI), according to the manufacturer’s instructions and
transformed into competent E. coli DH5a cells via electroporation.
Transformed bacteria were collected in 1 ml SOB medium, 150 ml
of the suspension were incubated overnight at 37uC on lysogeny
broth/ampicillin agar plates inoculated with 5-bromo-4-chloro-3-
indolyl-b-D-galactoside (X-Gal: 25 ml; 10%) and isopropyl-b-D-
thiogalactopyranoside (IPTG: 30 ml; 0.1 M) solved in dimethyl
sulfoxide. Colonies were picked and their plasmid inserts were
amplified using T7 and SP6 primers in a 35- cycles PCR with an
annealing temperature of 49uC and otherwise identical conditions,
as described above. 5 ml of each PCR product were analyzed on a
1.5% agarose gel, another 2 ml were purified with the NucleoFast 96
PCR kit (Macherey-Nagel) and used for the sequencing reaction
(BigDye Terminator Kit, Applied Biosystems, Foster City, CA) that
was performed according to the manufacturer’s instructions.
Sequencing reaction products were purified with the Sequencing
Reaction Cleanup Kit (Millipore, Billerica, MA) and resolved by
electrophoresis on a 3730 DNA Analyzer (Applied Biosystems).
DNA sequences around the identified polymorphic sites were
analyzed via the Transcription Element Search System (TESS,
http://www.cbil.upenn.edu/cgi-bin/tess/tess). Putative binding
sites of transcription factors were additionally checked for their
function and occurrence within the brain according to the NCBI
database (http://www.ncbi.nlm.nih.gov/).
Table 1. Forward and reverse primers used for quantitative PCR and their specific annealing temperatures.
Gene symbol Orientation Primer sequence (59R39) qPCR assay Annealing temp. [uC]
Avpr1b forward GCCCCTAATGAAGATTCTACCAATGTGG 2
reverse CTGCAGCAGGCGCGGTGACT
Oxtr forward CAGTGAAGATGACCTTCATC 2
reverse CCTTCAGGTACCGAGCAGAG
Avp forward TCGCCAGGATGCTCAACAC 1 56
reverse TCCGAAGCAGCGTCTTGG
Gapdh forward CCATCACCATCTTCCAGGAGCGAG 1, 2 65
reverse GATGGCATGGACTGTGGTCATGAG
Hprt1 forward GTCAAGGGCATATCCAACAACAAAC 1, 2 57
reverse CCTGCTGGATTACATTAAAGCACTG
Atp2b1 forward CATTACGGAAAATACAGGAGAGC 1, 2 62
reverse TGCTTCCCAGACTAACTGAAGAA
Numbers for qPCR assay indicate the SYBR Green Kit used (1: Roche; 2: Qiagen).
doi:10.1371/journal.pone.0005129.t001
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PVN and SON were dissected from the hypothalamus of four
female F1 mice that were heterozygous for the recently described
C(40)T (rs50049109) single-nucleotide polymorphism (SNP) [25].
Total RNA was extracted using a Trizol (Invitrogen) chloroform
extraction protocol and reverse transcribed with Omniscript
(Qiagen GmbH, Hilden, Germany). 208 bp of the Avp transcript
containing the SNP at position C(40)T were amplified by PCR in
40 identical cycles of denaturation at 94uC for 1 min, annealing at
56uC for 1 min and elongation at 72uC for 1 min using Taq
polymerase (Fermentas) and 59 GAG CAG AGC CTG AGC
TGC ACA CAG T 39 as forward and 59 AGC AGA TGC TTG
GTC CGA AGC ACG 39 as reverse primers (MWG Biotech).
Amplified fragments were ligated into a vector and transfected into
competent E. coli cells that were grown overnight as described
above.
From each agar plate, 25 colonies containing insert DNA
(according to white/blue selection) were picked and sequenced.
The specific alleles from each transcript were determined by the
C(40)T polymorphism.
Avp promoter deletion and signal peptide polymorphism
in a freely-segregating F2 panel
Biallelic DNA sequence polymorphisms were assessed using a
custom-designed oligonucleotide pool and the GoldenGate assay
on an Illumina Sentrix Array Matrix platform (Illumina, San
Diego, CA). In the parental generation, the two polymorphisms
located in the coding sequence or the promoter of Avp display
opposite homozygosity in HAB (+/+ and CC) vs. LAB (2/2 and
TT) animals. A total of 508 F2 offspring of a HABxLAB F1
intercross progeny were phenotyped and genotyped at these two
loci based on DNA isolated from tail tips as described recently
[25]. Genotyping was performed using the manufacturer’s
protocol and genotypes were determined using the Illumina
BeadStudio software 3.1.0.0 and the genotyping module 3.1.12.
Twenty four samples were genotyped twice, assuring data quality
and reproducibility.
Statistical analyses
The presented data are given as means+SEM and were
statistically analyzed using SPSS 12.0. Two independent groups
were compared using the Mann-Whitney U-test. For three
independent groups, the nonparametric Kruskal-Wallis H-test
was used with post hoc Mann-Whitney U-test comparisons,
including sequential Bonferroni correction of the respective p-
values, if applicable. For correlation analysis, a Spearman-Rho
correlation analysis was performed. For allele-specific transcription
analysis, deviation from the expected value was estimated using
the chi-square test.
For the F2 panel, association analysis was performed using a
permutation approach (WG-Permer, www.mpipsykl.mpg.de/wg-
permer). Trait values were rank-transformed to protect against
artifacts. Analysis was done using a genotypic model, i.e. the three
genotypic classes possible for each of the phenotypes were treated
as a separate class each and global test on equality of the three
means was performed.
Results
Behavioral phenotype and Avp expression in LAB, HAB
and NAB mice
EPM. In accordance with our breeding strategy, LAB, HAB
and NAB male mice showed significant differences in the percent
of total test time spent on the open arms of the EPM (Fig. 1A), with
LABs spending most time (about 60%) on the open arms, HABs
least time (about 5%) and NAB animals displaying an intermediate
phenotype (about 30%; p,0.01 for all group comparisons).
Tail suspension and forced swim test. Male LAB animals
exhibited a dramatically decreased immobility in the tail
suspension test (Fig. 1B) (p,0.01 vs. HAB and NAB). Similarly,
LAB mice showed decreased floating time in the forced swim test
relative to HAB and NAB mice (p,0.01 each; Fig. 1C).
Gene and protein expression analysis and validation
Analysis of genome wide expression revealed a significantly
decreased Avp mRNA level in the PVN (p,0.05) and showed a
tendency towards the same direction in the SON (p,0.1) of LAB
compared to HAB mice. Importantly, no differences were
observed for Avpr1a, Avpr1b, Oxt or Oxtr (p.0.1) in the respective
brain regions investigated (Table 3).
Confirming microarray data, ISH revealed a decreased
expression of Avp in both the PVN (Fig. 1D) and SON (Fig. 2A)
in male LAB compared to both HAB and NAB mice (PVN:
p,0.01 vs. HAB and NAB; SON: p,0.05 vs. HAB and NAB).
Table 2. Forward and reverse primers used for Avp sequencing and their specific annealing temperatures.
No. Forward primers (59R39) Reverse primers (59R39) Annealing temp. [uC]
01 GACACAGTGTGCCTCTATG GCTCTCCTGGACCTTCTG 39 56
02 AATACTCTAGGAAGAAGACAA GAAACAGCTTCCTGGTCA 39 56
03 GGACATGCCACTCAAGGG TACAGGCGTGCATCACGG 39 56
04 CTAGAAGCCGTGGGCTAGGT GGTGGGGAGAGCTTGGGAATAG 52
05 CATTGCCACCATAGCTTTC CTCTTGGGCAGTTCTGGAAG 52
06 GAGCAGAGCCTGAGCTGCACACAGT ACATACAATACAACAGATCTG 56
07 CCATGCCCAAGTGGAGC GCTGGAACGAGGCCAAG 56
08 AAAGCAGCAGGTGACACTAGG CTATGCACGACTTCGGGTGTG 55
09 ACTCCGTGGATTCTGCCAAGC GATGCCTTCTGCTCCTGAGAC 55
10 GCACGGAAATAGACAAGATAG AACTGACCATCCTGAGCCACC 55
11 AGAGATTAGTCTCAGTGACCTG CTGGAGTTGTGAGGTGGTTGTG 55
12 ACGGCTCAAGGAGGTAGGCG AAGTGACCACAAAGCACGGAG 55
doi:10.1371/journal.pone.0005129.t002
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PVN (Fig. 1E) and SON (Fig. 2B) of both male and female LABs
compared to HAB or NAB animals (PVN of male mice: p,0.05
vs. HAB; SON of male mice: p,0.05 vs. HAB; PVN of female
mice: p,0.01 vs. HAB; SON of female mice: p,0.05 vs. HAB
and NAB). To address the question whether the described
differences in AVP transcript levels actually translate into
biologically relevant AVP peptide contents, we carried out
immunohistochemistry with an antibody directed against AVP.
Confirming ISH data, these experiments showed a decreased
amount of AVP peptide in LAB compared to HAB mice in the
PVN (Fig. 3).
In contrast to AVP, the structurally related hypothalamic
neuropeptide OXT failed to reveal any significant differences
among the lines (Fig. 4) as detected by ISH. Also, no differences in
the expression of Avpr1b or Oxtr (p.0.1) could be confirmed using
qPCR (Table 3). Likewise, V1a autoradiography failed to reveal
any difference between the HAB and LAB lines in a variety of
brain regions critically involved in the regulation of anxiety- and
depression-related behaviors, thus further strengthening the
concept that events upstream of the receptor contribute to the
behavioral phenotype of HAB and LAB mice (Table 3).
Polymorphic AVP alleles
Next we investigated whether differences in AVP expression
originate from differences in the sequence of HAB and LAB alleles
that could underpin differences in the recruitment of proteins
driving transcription. Sequencing of the Avp gene resulted in the
Figure 1. Alterations in behavior and vasopressin (Avp) expression. Phenotypic measures of HAB/NAB/LAB mice reflecting behavior (A) on
the elevated plus-maze (EPM), in the (B) tail-suspension test (TST) and (C) forced swim test (FST) and corresponding vasopressin (Avp) expression
patterns as measured by (D) in situ hybridization (ISH) in the paraventricular nucleus (PVN) in male mice and by (E) quantitative PCR (qPCR) in the
PVN of male and female mice. Data are shown as means+SEM; * p,0.05; ** p,0.01; *** p,0.001; Mann-Whitney-U test.
doi:10.1371/journal.pone.0005129.g001
Table 3. Regulation of gene products of the vasopressin and
oxytocin systems from the MPI24K platform-based microarray
experiment of HAB vs. LAB mice.
Gene symbol PVN SON
Avp T58.1 T53.2
1
Avpr1a T95.2
2 105.0
2
Avpr1b 105.0 100.0
3
Oxt T82.0 T80.0
3
Oxtr 100.0 102.0
3
Values indicate the percentage of gene expression in LAB compared to HAB
mice with HAB=100%. Superscript numbers indicate the validation status: (1)
significant gene expression differences confirmed by both quantitative PCR
(qPCR) and in situ hybridization; (2) no differences in gene expression confirmed
by receptor autoradiography; (3) no differences in gene expression confirmed
by qPCR and in situ hybridization, respectively.
doi:10.1371/journal.pone.0005129.t003
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to SNPs and one comprises a 12 bp deletion (Fig. 5).
The upstream promoter region contains two SNPs: T(22521)C
with LABs carrying cytosine and HABs thymine and C(21422)T
with LABs carrying thymine and HABs cytosine. Furthermore,
LAB mice miss a 12 bp segment mapping to D(22180–2191). The
gene-coding locus contains three SNPs: C(40)T with LABs
carrying thymine and HABs cytosine, A(1431)G with LABs
carrying guanine and HABs adenine and T(1527)C with LABs
carrying cytosine and HABs thymine (see also [25]). The
downstream enhancer region, also referred to as the intergenic
region between Avp and Oxt, contains three SNPs: A(+399)G with
LABs carrying guanine and HABs adenine, T(+476)G with LABs
carrying guanine and HABs thymine and C(+2444)A with LABs
carrying adenine and HABs cytosine. A detailed in silico search for
Figure 2. Gene expression of HAB, NAB, LAB, and HABxLAB F1 intercross mice. Vasopressin (Avp) mRNA expression in the supraoptic
nucleus (SON) measured by (A) in situ hybridization (ISH) and (B) quantitative PCR (qPCR) under basal conditions in male and female mice. Data are
shown as means+SEM; T p,0.1; * p,0.05; ** p,0.01; Mann-Whitney-U test.
doi:10.1371/journal.pone.0005129.g002
Figure 3. Vasopressin (AVP) immunohistochemistry analysis.
AVP fluorescence antibody-staining of the paraventricular nucleus
(PVN) flanking the 3rd ventricle (3V) in HAB and LAB mice. For
corresponding in situ hybridization, see Fig. 7.
doi:10.1371/journal.pone.0005129.g003
Figure 4. Oxytocin (Oxt) mRNA expression. Oxt in the paraven-
tricular nucleus (PVN) measured by in situ hybridization under basal
conditions in male HAB, NAB and LAB mice. Data are shown as
means+SEM.
doi:10.1371/journal.pone.0005129.g004
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led to the identification of a number of candidates that are
summarized in Table 4.
In all our studies, involving LAB, HAB, NAB and F2 mice, the
C(40)T SNP and 12 bp deletion were in complete linkage, i.e. the
homozygous LAB-specific combination of alleles (TT) at the 40
th
bp of the transcript-coding sequence was strictly associated with
the absence of the 12 bps of the promoter. In analogy, if the
transcript-coding alleles were CT or CC, the 22180–2191 locus
bore the +/2 and +/+ allelic constellation, respectively. The most
frequent genotypic combination in NAB mice was the HAB-
specific one (Table 5).
Allele-specific Avp transcription in heterozygous
HABxLAB F1 intercross mice
To obtain evidence for a functional role of these polymorphisms
in contributing to different levels of AVP expression in male and
female LAB vs. HAB mice, we studied the activity of each allele in
an F1 intercross. Under this condition, both alleles are contained
in the same cellular background, thus eliminating differential
synaptic input as a confounding factor. In support of an allele-
dependent effect, heterozygous F1 mice revealed intermediate
levels of Avp mRNA expression in the SON in comparison to LABs
and HABs (p,0.1 F1 vs. HAB and LAB, p,0.05 LAB vs. HAB;
Fig. 2A). In line with these findings, the LAB-specific allele
displayed a significantly decreased expression relative to the HAB-
specific one in both the PVN and SON (p,0.001; Fig. 6),
consistent with Avp mRNA expression data of HAB vs. LAB mice
(see Figs. 1D, E; 2A, B).
Correlation of Avp mRNA in the PVN and anxiety/
depression-like behaviors of HAB, F1 and LAB mice
In light of the above data pointing to a dual role of
hypothalamic AVP in contributing to HAB and LAB phenotypes,
respectively, we performed correlation analyses with the aim to
obtain a more detailed picture of AVP’s role in anxiety- and
depression-like behaviors. Avp mRNA expression in the PVN of
male LAB, F1 and HAB mice under basal conditions is
significantly correlated with anxiety-related behavior (r=0.619;
p,0.001; Fig. 7A) as well as depression-like behavior (r=0.655;
p,0.001; Fig. 7B).
Association between the phenotype and polymorphisms
at the AVP locus
To further test their functional involvement, the Avp-related
polymorphisms were analyzed in a freely-segregating F2 panel
(n=508). In a total of 258 male mice with HAB grandmothers, 49
animals were identified as carrying the LAB-typical polymor-
phisms, i.e. the 12 bp deletion and the C(40)T in the combination
2/2 and TT, 67 animals the HAB-typical +/+ and CC and 142
animals the heterozygous +/2 and CT genotypes. In all F2
animals, the allele distribution roughly reflected a 1:2:1 ratio
(Table 6). If these polymorphisms have an impact on anxiety-
Figure 5. Vasopressin (Avp) gene sequence of HAB vs. LAB mice. Polymorphic sites are indicated with positions from transcription start (21
to 22600 bp) in (A) the promoter region (two SNPs and deletion in LABs); (B) within the Avp coding sequence from transcription start (1 to 1960 bp;
three SNPs); (C) in the intergenic region between Avp and oxytocin (Oxt) from the end of the last exon (+1t o+2600 bp; three SNPs). Exons and
untranslated regions (UTRs) are indicated by boxes (exons shaded, UTRs completely filled black or white).
doi:10.1371/journal.pone.0005129.g005
Table 4. Polymorphisms in the promoter and downstream
enhancer region between the HAB and LAB specific sequence
with probable binding factors.
Polymorphism 1st binding factor 2nd binding factor Reference
T(22521)C NF-1 C/EBPalpha (49,50)
D(22180–2191) NF-1 C/EBPbeta (48,49)
C(21422)T —
A(+399)G c-Ets-2 C/EBPbeta (51)
T(+476)G AP-1 / GATA-1
C(+2444)A —
doi:10.1371/journal.pone.0005129.t004
Table 5. Allele frequency in a NAB population (n=165) for
the SNP in the Avp signal peptide and the strictly linked
promoter deletion.
Locus (40) Frequency in NAB D(22191–2180)
CC 73.3% +/+
CT 26.1% +/2
TT T0.6% 2/2
doi:10.1371/journal.pone.0005129.t005
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should behave less anxious than their +/+ and CC counterparts.
Indeed, a co-segregation could be detected with 2/2 and TT mice
being significantly less anxious on the EPM (p,0.05; Fig. 8A).
Importantly, this association of the genetic polymorphisms with
anxiety levels was independent of locomotor activity, measured in
the open field (Fig. 8B). In the remaining 250 F2 male mice with
LAB grandmothers, no association was detectable (data not shown).
Discussion
In this study, we identified polymorphisms in the Avp gene
underlying a decreased expression of Avp mRNA in the
hypothalamus of LAB animals under basal conditions compared
to HAB, NAB and F1 mice, irrespective of gender. Both
correlative and associative evidence indicates that the hypomor-
phic Avp allele causally contributes to the locomotion-independent
reduction of anxiety-related behavior typical of LAB mice.
Importantly, differences in Avp expression were not accompa-
nied by changes in V1a and V1b receptors that could confound
the analysis of the behavioral involvement of AVP in these lines.
Several groups independently reported an association of the V1a
receptor with anxiety-related behavior. V1a receptor knockout
mice, although at times providing inconsistent results, showed
impaired social interaction, social recognition and reduced
anxiety-related behavior [38–40]. Furthermore, V1a antisense
RNA targeting the septum made rats less anxious [21]. Similarly,
V1b antagonism was found to reduce anxiety- and depression-like
behaviors [41,42]. In the present study, expression profiling in
combination with qPCR and receptor autoradiography revealed
no V1a/b-related difference between HAB and LAB mice in a
variety of anxiety-associated brain regions, suggesting that line-
specific divergences in behavior are primarily due to events
upstream of the receptor, i.e. differential expression and release of
AVP.
Despite the high sequence homology of the evolutionary related
and tail-to-tail oriented Avp and Oxt genes that are separated by
4 kbp, the so-called intergenic region [43], and despite the
anxiolytic potency of the central OXT system [44,45], differences
in gene expression were only restricted to the former. This is
consistent with the idea that our bidirectional breeding protocol
selects for genetic variation in specific anxiety-related signaling
pathways rather than disrupting hypothalamic functions in
general.
To identify the molecular mechanisms underlying the reduced
Avp expression, we sequenced the Avp-coding region and the
surrounding structures. Nine polymorphic loci were identified
reliably differing between HAB and LAB mice; all structural parts,
the upstream promoter, the gene locus and the downstream
enhancer region, contained three polymorphisms each. How may
the polymorphisms in the promoter region translate into different
expression profiles and phenotypes? While the C(21422)T SNP is
not located in a known transcription factor binding site, the
T(22521)C SNP and the D(22180–2191) deletion are located
directly in the center of a binding site for nuclear factor 1 (NF-1).
This well-described transcription factor in the brain has the
potential to enhance or impair gene expression, depending on the
concomitance of a C/EBP binding site [46–49]. At the D(22180–
2191) deletion site, the binding of NF-1 would be impaired. The
Figure 6. Allele-specific vasopressin (Avp) expression. Proportion
of HAB allele-specific vs. LAB allele-specific Avp transcripts from
heterozygous F1 (HABxLAB intercross) mice in the paraventricular
nucleus (PVN; x
2=14.4 p=1.4e-4) and the supraoptic nucleus (SON;
x
2=15.2 p=4.8e-5). Data are shown as means+SEM; *** p,0.001.
doi:10.1371/journal.pone.0005129.g006
Figure 7. Correlation between gene expression and behavior. Correlation of vasopressin (Avp) mRNA expression in the paraventricular
nucleus (PVN) with (A) anxiety-related behavior and (B) depression-like behavior of HAB, F1 and LAB male mice under basal conditions. For
corresponding immunohistochemistry, see Fig. 3.
doi:10.1371/journal.pone.0005129.g007
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concomitant C/EBP site, thus ultimately contributing to reduced
gene expression. Thus, both polymorphic sites are likely to lead to
an impaired Avp expression in mice bearing the LAB-specific DNA
sequence.
While there were no polymorphisms identified in the non-coding
(untranslated region and intronic) sequences, all three SNPs in the
gene locus were located in the coding sequence. Two of these are
silent mutations (A(1431)G and T(1527)C), and the third one
(C(40)T) causes a substitution of alanine to valine in the third amino
acid of the AVP signal peptide. As already reported by Keßler et al.
[25], this genetic marker co-segregated in an F2 panel with
symptoms of central diabetes insipidus in LAB mice and, partially,
with anxiety-related behavior, further confirming the strict linkage
between the promoter deletion D(22180–2191) and C(40)T.
Also SNPs in the downstream enhancer region can have an
impact on expression. There is a repetition of motifs from the 178-
bp region between +370 bp and +480 bp [43], where two further
SNPs have been identified. Analysis of this region resulted in the
identification of a binding site for c-Ets-2 near a binding site of C/
EBPbeta [48]. In the center of the c-Ets-2 binding site, the
A(+399)Gpolymorphismwouldallowforanenhancedtranscription
rate in the HAB-specific but not the LAB-specific DNA sequence.
Finally, even polymorphisms in the coding region are likely to
contribute to lower Avp mRNA content in LAB mice by negatively
influencing mRNA secondary structure and stability [50].
Still, we had to make sure that Avp under-expression in LAB
mice is definitely due to the described genetic polymorphisms
rather than to differences in other variables, including epistatic
gene-gene interactions or synaptic input to the hypothalamic
nuclei, likely to differ between the lines. Therefore, to eliminate the
enormous complexity of the intact organism, we decided to use
allele-specific transcription analysis, which had already been
successfully applied in HAB/LAB rats [18]. By cross-mating
HAB and LAB mice, we produced heterozygous F1 animals that
host both HAB and LAB line-specific alleles in each cell. The
analysis revealed a strongly decreased expression of Avp but not Oxt
by the LAB-specific allele compared to the HAB-specific one, thus
further confirming that line-specific polymorphisms are causally
related to line-specific expression profiles of Avp and, consequently,
the phenotype of trait anxiety.
However, while AVP expression is clearly under genetic control,
the regulation of anxiety-related behavior is more complex.
Compounding the difficulties associated with detecting multiple
small or moderate genetic effects, the latter operate via subtle
interactions with each other and the environment, thus further
masking the functional significance of given polymorphisms as
described here. Therefore, we used different approaches to
examine the possible contribution of the hypomorphic allele-
driven AVP deficit to trait anxiety, including correlational analyses
in HAB/F1/LAB mice and association studies in F2 animals.
Importantly, experimental crosses such as an F2 intercross are not
subject to allelic association between genes on different chromo-
somes, thus eliminating spurious associations between markers and
phenotypes [51]. Indeed, in addition to correlative evidence, a
significant, though moderate association between the promoter
deletion and the C(40)T SNP and locomotion-independent
anxiety-related behavior was demonstrated in a freely-segregating
F2 panel, indicative of a causal contribution to the phenotype. It is
of note in this context that these F2 animals were assigned
according to their Avp-related genotype, while all the other
(anxiety-relevant) genes freely segregated, explaining why differ-
ences in anxiety-related behavior are rather modest (Fig. 8A)
compared to those seen in Fig. 1A.
As mentioned before, the individual phenotype is known to be
shaped by phenomena that are or are not mediated by sequence
Figure 8. Association between anxiety-related behavior and
the Avp-related genotypes in the freely-segregating F2 panel.
Phenotypic indices of male F2 mice with HAB grandmothers and Avp-
related genotypes (+/+) and CC (HAB-typical homozygotes, n=67), (+/
2) and CT (heterozygotes, n=142), or (2/2) and TT (LAB-typical
homozygotes, n=49). (A) % time spent on the open arms of the
elevated plus-maze (EPM) and (B) total distance traveled in the open
field (OF). LAB-typical homozygotes were less anxious, independent of
locomotor activity. Data are shown as means+SEM; * p,0.05.
doi:10.1371/journal.pone.0005129.g008
Table 6. Allele frequency in a freely-segregating F2 panel
(HABxLAB intercross offspring, n=508) for the SNP in the Avp
signal peptide and the strictly linked promoter deletion.
Locus (40) Frequency in NAB D(22191–2180)
CC 25.9% +/+
CT 51.9% +/2
TT 23.2% 2/2
doi:10.1371/journal.pone.0005129.t006
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mental, with the latter primarily relying on the quality of mother-
infant interaction [52]. To reduce possible influences of different
epigenetic effects, deriving from the fact that half of the F2 had
LAB and the other half HAB grandmothers, split calculations
according to the grandmaternal background were performed for
associations. Indeed, a significant association at the Avp locus was
found for F2 mice with HAB grandmothers. Thus, while the
polymorphisms identified in the Avp gene are unlikely to generally
cause hypo-anxiety, their variation may contribute to the severity
of the phenotype, further confirming the molecular basis of many
small or moderate genetic effects giving rise to trait anxiety. In
other words, while the link between genes, the brain and behavior
remains weak, variation in the Avp locus may be one contributor,
among many others, to trait anxiety. Several dozen quantitative
trait loci, containing one gene or several genes, may be involved in
anxiety regulation, and most of them are yet to be identified
[53,54].
Further studies will focus on the importance of the (grand)pa-
rental background for anxiety-related behavior, as genes regulated
by (grand)parent-specific epigenetic modifications can lead to
monoallelic gene expression [55,56] or are simply X- or Y-linked.
As there is a higher prevalence of anxiety and depression in
women than in men [57], the (grand)parental influence on
anxiety-related behavior, as revealed in our F2 panel, might also
be due to a modulating effect of a sex-specific locus. HAB/LAB
mice might thus represent a model to further investigate the
complex pattern of genetic vs. epigenetic inheritance.
As LAB mice exhibit a deficit not only in AVP precursor
processing and neuropeptide release from both dendrites and axon
terminals [25], but also in Avp expression, additive effects at
multiple levels are likely to produce a more or less ‘‘global’’ deficit
in bioactive AVP. Remarkably, recent studies in Brattleboro rats
and humans confirmed that an AVP deficit may be accompanied
by symptoms of central diabetes insipidus, reduced anxiety-related
or attenuated depression-like behavior [58] and signs of dimin-
ished agoraphobia [15], respectively, suggesting complementary
inter-species genetics.
Determining the most common Avp-related genotypes in the
NAB line revealed that the HAB-specific polymorphisms represent
the most common genetic variant. More than 70% of the NAB
mice were found to be homozygous for the HAB-specific
sequence, whereas less than 1% carried the LAB-specific allele
homozygously. Nevertheless, the respective distribution is in
Hardy-Weinberg equilibrium, although with the LAB-specific
allele at a decreased frequency. The fact that the NAB line’s most
common genotype for the Avp gene and surrounding sequence
fully corresponds to the HAB-specific sequence helps to explain
the often observed discrepancy between NAB and F1 mice, both of
which are often used as controls. In contrast to strictly
intermediate F1, NAB mice displayed in about 70% of all animals
a HAB-like Avp expression and depression-like behavior in the tail-
suspension test (Fig. 1B, D, E and [24]), which has also been
demonstrated recently in an unselected CD1 population [59], thus
further emphasizing the functional implications of centrally
released AVP.
The application of similar breeding strategies in two different
species (Rattus norvegicus and Mus musculus) resulted in similar
findings concerning the identification of polymorphisms in and
around the Avp gene and both the expression and release patterns
of AVP. This was shown to be likely involved in mediating
anxiety-related behavior. While these results cannot entirely
exclude an effect of genetic drift, they strongly point to an
evolutionary conserved dynamic role of AVP along a continuum,
with hypomorphic Avp alleles finally contributing to low anxiety-
and possibly depression-like behaviors and hypermorphic alleles
contributing to hyper-anxiety. Together with human studies
[23,60], they do not only ensure the construct validity of the
HAB/LAB model, but additionally provide a strong impetus for
Avp expression as a potential biomarker and therapeutic target in
psychopathology.
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